|
Careers |
|
Bioanalytical ScientistDrug Metabolism/PharmacokineticsSUMMARY: Working in a GLP environment, the Bioanalytical Scientist is responsible for day-to-day execution of bioanalytical protocols in support of Phase 1 clinical trials, including pharmacokinetics, absolute bioavailability, metabolite profiling, mass balance and microdosing studies. Clinical studies are conducted using compounds that are lightly labeled with 14C isotope. These Phase 1 studies are typically performed in 6-18 healthy volunteers over several days at a single clinical site. The clinic submits the samples to Accium BioSciences for processing and quantitation on Accium’s 0.5 mV Accelerator Mass Spectrometer (AMS), an ultra-sensitive mass spectrometer capable of quantifying drugs present at attomole (10^-18 M) concentration. The Bioanalytical Scientist is responsible for front-end sample preparation, HPLC and processing prior to transfer to Graphitization and AMS Laboratories. The position reports to the Study Director. ESSENTIAL DUTIES AND RESPONSIBILITIES:
Requirements:
About Accium BioSciences: Accium BioSciences is a privately-held contract research company offering ultrasensitive bioanalytical services in support of early-phase clinical trials. The company’s clients are primarily large pharmaceutical companies investigating the bioavailability, pharmacokinetics and metabolism (PK/ADME) of new chemical entities. Our services are based on accelerator mass spectrometry (AMS), a detection platform for quantifying drugs and metabolites in clinical samples with unprecedented sensitivity. In April 2006, Accium BioSciences launched the first US-based AMS Facility in the U.S dedicated to pharmaceutical services. The company is based in Seattle, Washington. For more information, please visit www.acciumbio.com, or call Ali Arjomand (206) 281-3915, e-mail arjomand@acciumbio.com. |
Copyright © Accium BioSciences, Inc. 2004-2010 |